Literature DB >> 30324518

The Study of Brain Tumor Stem Cell Invasion.

Rawan Al-Kharboosh1,2, Montserrat Lara-Velazquez1,3, Luis Prieto2, Rachel Sarabia-Estrada1, Alfredo Quiñones-Hinojosa4.   

Abstract

Ninety percent of deaths from solid tumors have been ascribed to the invasion and metastatic dissemination of cancer cells. One of the most fundamental prerequisites of brain tumor stem cell invasion is their ability to penetrate and traverse through the basement membrane and stromal compartments displacing from their original point of origin and repopulating at a distant site and adjacent tissue. In order to propose a successful clinical strategy, the investigation of the molecular determinants of invasion must factor in measurements and predictors of the complexity of brain tumor invasion potential accounting for the physiological scenarios encountered in the tumor niche. This chapter will highlight some laboratory approaches such as: spot assay, 3D chemogradient chambers, Fluoroblok™ tumor invasion, organotypics, and 3D tumor spheroid assays that could help mitigate the investigation of a tumor stem cell's invasion capacity through restrictive 3D environments otherwise seen in vivo.

Entities:  

Keywords:  BTICs; Invasive capacity; Motility

Mesh:

Year:  2019        PMID: 30324518      PMCID: PMC6379892          DOI: 10.1007/978-1-4939-8805-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.

Authors:  Chris L Smith; Kaisorn L Chaichana; Young M Lee; Benjamin Lin; Kevin M Stanko; Thomas O'Donnell; Saksham Gupta; Sagar R Shah; Joanne Wang; Olindi Wijesekera; Michael Delannoy; Andre Levchenko; Alfredo Quiñones-Hinojosa
Journal:  Stem Cells Transl Med       Date:  2015-02-02       Impact factor: 6.940

2.  Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.

Authors:  Sara Abbadi; Julio J Rodarte; Ameer Abutaleb; Emily Lavell; Chris L Smith; William Ruff; Jennifer Schiller; Alessandro Olivi; Andre Levchenko; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa
Journal:  Mol Cancer Res       Date:  2014-07-07       Impact factor: 5.852

3.  Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes.

Authors:  Chris L Smith; Onur Kilic; Paula Schiapparelli; Hugo Guerrero-Cazares; Deok-Ho Kim; Neda I Sedora-Roman; Saksham Gupta; Thomas O'Donnell; Kaisorn L Chaichana; Fausto J Rodriguez; Sara Abbadi; JinSeok Park; Alfredo Quiñones-Hinojosa; Andre Levchenko
Journal:  Cell Rep       Date:  2016-06-09       Impact factor: 9.423

Review 4.  In vitro cell migration and invasion assays.

Authors:  Nina Kramer; Angelika Walzl; Christine Unger; Margit Rosner; Georg Krupitza; Markus Hengstschläger; Helmut Dolznig
Journal:  Mutat Res       Date:  2012-08-23       Impact factor: 2.433

Review 5.  Initial steps of metastasis: cell invasion and endothelial transmigration.

Authors:  Franziska van Zijl; Georg Krupitza; Wolfgang Mikulits
Journal:  Mutat Res       Date:  2011-05-12       Impact factor: 2.433

  5 in total
  2 in total

1.  IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.

Authors:  Shashwat Tripathi; Tito Vivas-Buitrago; Ricardo A Domingo; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; Wendy Sherman; Vivek Gupta; Erik H Middlebrooks; David S Sabsevitz; Alyx B Porter; Joon H Uhm; Bernard R Bendok; Ian Parney; Fredric B Meyer; Kaisorn L Chaichana; Kristin R Swanson; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2021-10-29       Impact factor: 5.408

2.  Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.

Authors:  Tito Vivas-Buitrago; Ricardo A Domingo; Shashwat Tripathi; Gaetano De Biase; Desmond Brown; Oluwaseun O Akinduro; Andres Ramos-Fresnedo; David S Sabsevitz; Bernard R Bendok; Wendy Sherman; Ian F Parney; Mark E Jentoft; Erik H Middlebrooks; Fredric B Meyer; Kaisorn L Chaichana; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2021-06-04       Impact factor: 5.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.